Anita Joshi, D.M.D., MPH

Affiliate Member

Research Program:

Cancer Prevention and Population Sciences

Faculty Rank:

Doctoral Candidate

Campus:

University of Arkansas for Medical Sciences

Department:

Epidemiology

Cancer Research Interest

Disease Site Focus: Thoracic/ Lung
Research Focus Area: Treatment, Health Disparities, Prevention
Type of Research: Population Sciences, Clinical
Research Keywords: Immune Checkpoint Inhibitors, Lung Cancer, Lung cancer screening, Cardiotoxicity, APCD
Research Interest Statement: My dissertation project uses population-based state cancer registry data linked to multi-payer medical and pharmacy claims to examine risk of Cardiotoxicity among lung cancer patients, specifically in those receiving Immune checkpoint inhibitors (ICIs). I will be using a longitudinal study design to compare risk of cardiotoxic events among lung cancer patients receiving various classes of these drugs as well as a comparison in those receiving ICIs with or without concurrent radiation. In addition, my research will assess disparities in lung cancer screening and how these disparities translate into short term adverse outcomes following lung cancer treatment.

Joshi A, Su LJ, Orloff MS. Tuberculosis and Risk of Emphysema among US Adults in the NHANES I Epidemiologic Follow-Up Study Cohort, 1971-1992. Epidemiologia (Basel, Switzerland). 2023 4(4):525-537. PMID: 38131676. PMCID: PMC10871094.
Rao SM, Knott PD, Sweeny L, [et al., including Joshi AS]. Microvascular Free Flap Outcomes in Maxillectomy Defects from Invasive Fungal Sinusitis. The Laryngoscope. 2023. PMID: 37772913.